tiprankstipranks
TipRanksTop Financial ExpertsInsidersLawrence Otto Klein

Lawrence Otto Klein Insider Profile

4 Followers
Lawrence Otto Klein, CEO, Director at Oruka Therapeutics, holds 925.58K shares in Oruka Therapeutics (Ticker: ORKA), holds ― shares in Jade Biosciences (Ticker: JBIO), holds 24.50K shares in Jasper Therapeutics (Ticker: JSPR).
See the Hottest Stocks Based on Insider Trading >
tipranks
Lawrence Otto Klein

Lawrence Otto Klein
Oruka Therapeutics (ORKA)
CEO, Director

Ranked #98,114 out of 108,921 Corporate Insiders

Profitable Transactions

0%
0 out of 2 Profitable Transactions

Average Return

-79.10%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
How are Insiders Ranked?

Insider Holdings

$89M
98.09%
1.65%
0.24%
0.02%
0.00% Others
A breakdown of Lawrence Otto Klein's holdings
See the Top Stocks by Insiders

Insider Roles

Oruka Therapeutics
(ORKA)
CEO, Director
Crispr Therapeutics AG
(CRSP)
CBO & COO
Dyne Therapeutics
(DYN)
Director
Jasper Therapeutics
(JSPR)
Director
+1 other positions
Roles that Lawrence Otto Klein holds in companies
See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:
Oruka Therapeutics
(ORKA)
Rating:Informative Sell
Date:Jun 15, 2026 - Today
Return:-34.30%
The most profitable trade made by Lawrence Otto Klein
See the Latest Stocks Traded by Insiders

Lawrence Otto Klein's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
ORKA
Oruka Therapeutics
Sep 01, 2026
CEO, Director
Uninformative Buy
585.00K
$87.29M
JBIO
Jade Biosciences
―
Director
―
―
CRSP
Crispr Therapeutics AG
Mar 14, 2022
CBO & COO
Uninformative Buy
279.42K
$1.47M
DYN
Dyne Therapeutics
Sep 23, 2020
Director
Uninformative Buy
―
$217.82K
JSPR
Jasper Therapeutics
Oct 13, 2022
Director
Uninformative Buy
―
$17.37K
List of latest transactions for each holding click on a transaction to see Lawrence Otto Klein's performance on stock
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Lawrence Otto Klein insider profile FAQ

What is the percentage of profitable transactions made by Lawrence Otto Klein?
The percentage of profitable transactions made by Lawrence Otto Klein is 0%.
    What is the average return per transaction made by Lawrence Otto Klein?
    The average return per transaction made by Lawrence Otto Klein is -79.10%.
      What stocks does Lawrence Otto Klein hold?
      Lawrence Otto Klein holds: ORKA, JBIO, CRSP, DYN, JSPR stocks.
        What was Lawrence Otto Klein’s latest transaction?
        Lawrence Otto Klein latest transaction was an Uninformative Buy of $585.00K.
          What was Lawrence Otto Klein's most profitable transaction?
          Lawrence Otto Klein’s most profitable transaction was an Informative Sell of ORKA stock on June 15, 2026. The return on the trade was -34.30%.
            What is Lawrence Otto Klein's role in Oruka Therapeutics?
            Lawrence Otto Klein's role in Oruka Therapeutics is CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.